Weight Loss Sleep

Gene Therapy for Infants, Sleep Science for the Awake, and the Dangers of Unapproved Drugs

CBS News reported that some doctors are prescribing the unapproved weight-loss drug retatrutide, a pattern that reflects broader dynamics in an obesity-treatment market where demand for effective therapies far exceeds approved supply. When established treatments such as Ozempic face shortages, practitioners and patients are turning to alternatives ahead of regulatory clearance.

AstraZeneca offered a contrast in the form of legitimate Phase Three trial data for its obesity pill, which achieved 11.8 percent weight loss at thirty-six weeks with no plateau observed. That absence of diminishing returns is notable because most weight-loss interventions show reduced efficacy over time, suggesting the mechanism of action may differ from existing treatments.

In a development described as a first of its kind, an Israeli medical team delivered gene therapy directly to the brain of an eight-month-old patient with severe genetic epilepsy, using viral vectors to supply missing genes to neural tissue. The blood-brain barrier has historically blocked most therapeutic approaches from reaching neurons, making the successful delivery both a technical and a safety milestone for a condition previously considered untreatable.

NIH-funded research demonstrated the ability to trigger restorative sleep benefits in subjects who are awake — a finding with potential implications for shift workers, aging research, and space exploration, as well as for the hundreds of billions of dollars in annual economic losses attributed to sleep disorders. A startup separately unveiled the first wearable device for continuous cortisol monitoring, moving stress measurement from periodic lab snapshots to real-time physiological data. Against these advances, Reuters reported that nearly two dozen Epstein survivors face renewed threats and harassment following botched redactions by the Department of Justice that exposed their identities — institutional failures with direct consequences for vulnerable individuals and for future reporting of similar crimes.